Investors locked in profits on Marinus Pharmaceuticals Inc. (Nasdaq: MRNS). Shares of the biopharmaceutical dropped $1.44 to close at $7.89.
Profit taking weighs down Marinus Pharmaceuticals
December 15, 2017 at 18:47 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|